Panacos Pharmaceuticals, Inc.
PANC · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $4,198 | $20,260 | $23,855 | $645 |
| - Cash | $37,865 | $33,140 | $87,138 | $4,879 |
| + Debt | $19,311 | $361 | $213 | $164 |
| Enterprise Value | -$14,356 | -$12,519 | -$63,070 | -$4,070 |
| Revenue | $180 | $284 | $1,049 | $1,337 |
| % Growth | -36.6% | -72.9% | -21.5% | – |
| Gross Profit | $180 | $284 | $1,049 | $1,337 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$38,228 | -$40,944 | -$39,938 | -$11,742 |
| % Margin | -21,237.8% | -14,416.9% | -3,807.2% | -878.2% |
| Net Income | -$37,459 | -$38,110 | -$59,078 | -$12,038 |
| % Margin | -20,810.6% | -13,419% | -5,631.8% | -900.4% |
| EPS Diluted | -0.7 | -0.75 | -1.72 | -14.51 |
| % Growth | 6.7% | 56.4% | 88.1% | – |
| Operating Cash Flow | -$31,035 | -$29,630 | -$21,646 | -$9,773 |
| Capital Expenditures | -$48 | -$519 | -$150 | -$76 |
| Free Cash Flow | -$31,083 | -$30,149 | -$21,796 | -$9,849 |